Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,102.00
Bid: 1,100.00
Ask: 1,104.00
Change: -14.00 (-1.25%)
Spread: 4.00 (0.364%)
Open: 1,154.00
High: 1,154.00
Low: 1,102.00
Prev. Close: 1,116.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

21 Jul 2014 07:00

RNS Number : 7799M
CVS Group plc
21 July 2014
 

 

21 July 2014

 

CVS Group plc ("CVS" or the "Group")

 

Trading Update

 

CVS, the UK's leading provider of integrated veterinary services, is pleased to provide the following trading update in respect of the financial year ended 30 June 2014. Comparative data relates to the year ended 30 June 2013 unless otherwise stated. The Group will announce its full year results on Friday 19 September 2014 and these are expected to be in line with market expectations.

 

Group revenue for the year showed total like-for-like growth of 6.9%. This figure benefitted from good weather throughout the winter months and is stated after adjusting for one extra day's trading in the year to 30 June 2013. Like-for-like sales performance was strong in all the main businesses, particularly in Animed Direct. CVS continues to see opportunities for organic growth across all of its activities and continues to invest in the estate to capitalise on this potential.

 

Strong organic growth has been achieved in the core veterinary practices especially in the second half of the year. Membership of our Healthy Pet Club loyalty schemes grew by 50,100 (44.8%), from 111,900 pets at the start of the year to 162,000 at the year end. In the previous year membership grew by 46,400. Based on the current run rate these schemes are now contributing over 11% of the total revenue from practices (2013: 9%).

 

The scale and increasing density of our practice network has enabled the Group to open four emergency out-of-hours centres during the year, bringing work previously performed by third parties into the Group. Further opportunities for similar changes will be sought during 2015.

 

Good progress has been made in developing our referrals business with organic growth continuing in the centres that we already operate. In July 2014 we purchased the freehold of Lumbry Park, Alton, Hampshire for £800,000 and we are now developing plans for fitting it out as a first-class multi-disciplinary referral centre. This centre is expected to open in the summer of 2015.

 

It is pleasing to report that significant growth has continued in Animed Direct, our online dispensary. It is currently generating some £10.4 million of annualised revenue, based on revenue for June 2014, compared with £6.7 million based on June 2013. The varying regulatory requirements in Europe have led to a slight delay in launching our planned local language European websites and the first is now expected to be launched within the next few months.

 

Acquisition activity has continued to play an important part in the Group's strategy. In addition to the seven practices acquired in the first half of the year, three practices - 3 Mile (Glasgow), Ashfield (3 sites around Halifax) and Castle (3 sites in Barnard Castle, County Durham) - and a pet crematorium (Silvermere Haven in Cobham) were acquired during the second half. These acquisitions extend the Practice Division's operations and the practices are an excellent geographic fit with the Group's existing surgeries. The acquisition of Silvermere Haven is an important step in the geographic development of our Crematoria Division and will allow almost all of our practices to be serviced internally.

 

All of the acquisitions have been successfully integrated into the Group. The aggregate turnover of acquisitions in their last financial year prior to acquisition totalled £13.3 million. The actual post acquisition turnover of businesses acquired during the year ended 30 June 2014 was £6.6m.

 

The Group now operates a total of 262 veterinary practices across the UK, an on-line dispensary, 5 diagnostic laboratories and 3 pet crematoria.

 

 

The Board is encouraged by the recent improvement in like-for-like sales performance, the continuing potential for further acquisitions and the general progress in all divisions of the Group.

 

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer (Nominated Adviser & Broker) 020 7496 3000

Aubrey Powell / Alex Wright

Nick Owen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMNDRFGDZM
Date   Source Headline
13th Jan 20221:43 pmRNSBlock Listing Interim Review and TVR Update
4th Jan 20227:00 amRNSExercise of Options, PDMR Dealing and TVR
31st Dec 20217:00 amRNSExercise of Options and Total Voting Rights
22nd Dec 20212:37 pmRNSBlock Listing Application
17th Dec 20211:41 pmRNSGrant of Options
15th Dec 202111:30 amRNSPDMR/PCA Dealings
13th Dec 20217:00 amRNSPDMR/PCA Dealings
7th Dec 202111:06 amRNSPDMR/PCA Dealings
30th Nov 20217:00 amRNSExercise of Options and Total Voting Rights
26th Nov 20215:31 pmRNSHolding(s) in Company
26th Nov 20215:24 pmRNSHolding(s) in Company
26th Nov 20218:16 amRNSGrant of Options & PDMR Dealing
26th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20213:09 pmRNSResult of AGM
24th Nov 20217:00 amRNSAGM Statement and Trading Update
19th Nov 20214:26 pmRNSHolding(s) in Company
10th Nov 202111:17 amRNSHolding(s) in Company
3rd Nov 20212:30 pmRNSPCA Shareholding
1st Nov 20218:00 amRNSHolding(s) in Company
29th Oct 202110:17 amRNSPosting of Annual Report & Notice of AGM
29th Oct 20217:00 amRNSExercise of Options and Total Voting Rights
13th Oct 20216:01 pmRNSExercise of Options, PDMR Dealing and TVR
7th Oct 20211:52 pmRNSHolding(s) in Company
7th Oct 20217:00 amRNSLong Term Incentive Plan Awards & PDMR Dealing
30th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
29th Sep 20215:28 pmRNSHolding(s) in Company
28th Sep 20217:54 amRNSHolding(s) in Company
23rd Sep 20217:00 amRNSBoard Changes
23rd Sep 20217:00 amRNSFinal results for the year ended 30 June 2021
13th Sep 20211:50 pmRNSHolding(s) in Company
31st Aug 20217:00 amRNSExercise of Options and Total Voting Rights
27th Aug 20215:34 pmRNSHolding(s) in Company
26th Aug 20218:48 amRNSBlock Listing Application
24th Aug 20214:10 pmRNSHolding(s) in Company
20th Aug 20212:09 pmRNSHolding(s) in Company
20th Aug 20212:07 pmRNSHolding(s) in Company
30th Jul 202112:00 pmRNSExercise of Options and Total Voting Rights
29th Jul 20214:14 pmRNSHolding(s) in Company
20th Jul 20217:00 amRNSTrading Update
13th Jul 202112:40 pmRNSBlock Listing Interim Review and TVR Update
30th Jun 20217:00 amRNSExercise of Options and Total Voting Rights
28th May 202112:00 pmRNSExercise of Options and Total Voting Rights
13th May 20218:30 amRNSShareholder Consultation regarding 2020 AGM
30th Apr 202112:00 pmRNSExercise of Options and Total Voting Rights
30th Apr 20217:00 amRNSTrading Update
7th Apr 20217:00 amRNSDirector/PDMR Shareholding
31st Mar 20217:00 amRNSExercise of Options and Total Voting Rights
30th Mar 20219:06 amRNSDirector/PDMR and PCA Shareholding
25th Mar 20217:00 amRNSInterim Results
3rd Mar 20217:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.